StemRIM (4599)

Currency in JPY
319.0
-11.0(-3.33%)
Delayed Data·
4599 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4599 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
319.0331.0
52 wk Range
246.0465.0
Key Statistics
Bid/Ask
319.00 / 320.00
Prev. Close
330
Open
331
Day's Range
319-331
52 wk Range
246-465
Volume
113.1K
Average Volume (3m)
163.84K
1-Year Change
-13.6%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4599 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
700.0
Upside
+119.44%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

StemRIM News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

StemRIM Company Profile

StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. The company develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy. Its pre-clinical stage products include PJ2 and PJ3 to treat multiple tissue damage disease; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.

Employees
44
Market
Japan

Compare 4599 to Peers and Sector

Metrics to compare
4599
Peers
Sector
Relationship
P/E Ratio
−10.4x−6.6x−0.5x
PEG Ratio
−1.23−0.140.00
Price/Book
2.6x8.3x2.6x
Price / LTM Sales
-50.0x3.3x
Upside (Analyst Target)
113.4%72.4%43.4%
Fair Value Upside
Unlock8.2%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 700.0
(+119.44% Upside)

Earnings

Latest Release
Jun 11, 2025
EPS / Forecast
-6.76 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4599 Income Statement

FAQ

What Stock Exchange Does StemRIM Trade On?

StemRIM is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for StemRIM?

The stock symbol for StemRIM is "4599."

What Is the StemRIM Market Cap?

As of today, StemRIM market cap is 20.50B.

What Is StemRIM's Earnings Per Share (TTM)?

The StemRIM EPS (TTM) is -31.94.

When Is the Next StemRIM Earnings Date?

StemRIM will release its next earnings report on 09 Sept 2025.

From a Technical Analysis Perspective, Is 4599 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has StemRIM Stock Split?

StemRIM has split 0 times.

How Many Employees Does StemRIM Have?

StemRIM has 44 employees.

What is the current trading status of StemRIM (4599)?

As of 08 Aug 2025, StemRIM (4599) is trading at a price of 319.00, with a previous close of 330.00. The stock has fluctuated within a day range of 319.00 to 331.00, while its 52-week range spans from 246.00 to 465.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.